CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
Figure 2
Postoperative survival curves for patterns of patients with glioma and CD24 expression. (a) Kaplan-Meier postoperative survival curve for patterns of patients with glioma and CD24 expression. Unadjusted RR of CD24-negative and -positive groups were 1.0 and 0.02, respectively (). (b) Cox proportional hazards model after adjusting for age, gender, and grade. CD24 might be an independent predictor of survival, without consideration of age, gender, or grade. Adjusted RR of CD24-negative and positive groups were 1.0 and 0.04, respectively ().